DONALD E. BOBO JR - 02 Jun 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
02 Jun 2025
Net transactions value
-$198,911
Form type
4
Filing time
02 Jun 2025, 17:01:58 UTC
Previous filing
12 May 2025
Next filing
10 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BOBO DONALD E JR CVP,Strategy/Corp Development ONE EDWARDS WAY, IRVINE Linda J. Park, Attorney-in-Fact 02 Jun 2025 0001196661

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Sale $198,911 -2,570 -4.9% $77.40 50,356 02 Jun 2025 Direct F1, F2
holding EW Common Stock 38,818 02 Jun 2025 401(k)
holding EW Common Stock 135,152 02 Jun 2025 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.
F2 This transaction was executed in multiple trades at prices ranging from $77.36 to $77.68. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.